BioPorto A/S (FRA:2P4)

BioPorto Statistics

Total Valuation

BioPorto has a market cap or net worth of EUR 70.24 million. The enterprise value is 67.66 million.

Market Cap	70.24M
Enterprise Value	67.66M

Important Dates

The next estimated earnings date is Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	495.10M
Shares Outstanding	n/a
Shares Change (YoY)	+12.04%
Shares Change (QoQ)	+1.47%
Owned by Insiders (%)	0.43%
Owned by Institutions (%)	0.29%
Float	492.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.35
PB Ratio	14.91
P/TBV Ratio	14.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.82
EV / Sales	13.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.21

Financial Position

The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.24.

Current Ratio	1.91
Quick Ratio	1.63
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	-0.10
Interest Coverage	-57.52

Financial Efficiency

Return on equity (ROE) is -142.61% and return on invested capital (ROIC) is -81.09%.

Return on Equity (ROE)	-142.61%
Return on Assets (ROA)	-61.71%
Return on Invested Capital (ROIC)	-81.09%
Return on Capital Employed (ROCE)	-217.77%
Revenue Per Employee	101,985
Profits Per Employee	-242,114
Employee Count	48
Asset Turnover	0.41
Inventory Turnover	2.55

Taxes

Income Tax	-875,667
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.61% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-33.61%
50-Day Moving Average	0.14
200-Day Moving Average	0.16
Relative Strength Index (RSI)	42.54
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioPorto had revenue of EUR 4.90 million and -11.62 million in losses. Loss per share was -0.03.

Revenue	4.90M
Gross Profit	3.13M
Operating Income	-11.70M
Pretax Income	-12.50M
Net Income	-11.62M
EBITDA	-11.59M
EBIT	-11.70M
Loss Per Share	-0.03

Balance Sheet

The company has 3.69 million in cash and 1.12 million in debt, giving a net cash position of 2.58 million.

Cash & Cash Equivalents	3.69M
Total Debt	1.12M
Net Cash	2.58M
Net Cash Per Share	n/a
Equity (Book Value)	4.71M
Book Value Per Share	0.01
Working Capital	3.42M

Cash Flow

In the last 12 months, operating cash flow was -10.66 million and capital expenditures -230,030, giving a free cash flow of -10.89 million.

Operating Cash Flow	-10.66M
Capital Expenditures	-230,030
Free Cash Flow	-10.89M
FCF Per Share	n/a

Margins

Gross margin is 63.90%, with operating and profit margins of -238.98% and -237.40%.

Gross Margin	63.90%
Operating Margin	-238.98%
Pretax Margin	-255.29%
Profit Margin	-237.40%
EBITDA Margin	-236.70%
EBIT Margin	-238.98%
FCF Margin	n/a

Dividends & Yields

BioPorto does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.04%
Shareholder Yield	-12.04%
Earnings Yield	-16.55%
FCF Yield	-15.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioPorto has an Altman Z-Score of 0.16 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.16
Piotroski F-Score	2